send link to app

Intercept 302 EU Study


4.2 ( 3312 ratings )
Medizin
Entwickler Snapiot Inc
Frei

This telemedicine app is intended to be used by patients enrolled in Intercepts 302 EU study. The purpose of this app is to connect patients and clinicians for the purpose of Intercepts study. Patients will use this app to schedule and conduct telemedicine calls.

This app is intended for users who are age 18 and over.